JP2000513949A - 生物学的サンプル中における生物学的分子の検出のためのバクテリオファージの使用に基づく方法 - Google Patents
生物学的サンプル中における生物学的分子の検出のためのバクテリオファージの使用に基づく方法Info
- Publication number
- JP2000513949A JP2000513949A JP10550211A JP55021198A JP2000513949A JP 2000513949 A JP2000513949 A JP 2000513949A JP 10550211 A JP10550211 A JP 10550211A JP 55021198 A JP55021198 A JP 55021198A JP 2000513949 A JP2000513949 A JP 2000513949A
- Authority
- JP
- Japan
- Prior art keywords
- molecule
- interest
- bacteriophage
- capsid
- biological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 82
- 239000012472 biological sample Substances 0.000 title claims abstract description 35
- 241001515965 unidentified phage Species 0.000 title claims abstract description 32
- 238000001514 detection method Methods 0.000 title abstract description 19
- 210000000234 capsid Anatomy 0.000 claims abstract description 34
- 238000009739 binding Methods 0.000 claims abstract description 18
- 230000027455 binding Effects 0.000 claims abstract description 17
- 108020004414 DNA Proteins 0.000 claims description 48
- 238000003752 polymerase chain reaction Methods 0.000 claims description 29
- 102000005962 receptors Human genes 0.000 claims description 28
- 108020003175 receptors Proteins 0.000 claims description 28
- 239000003446 ligand Substances 0.000 claims description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 239000000427 antigen Substances 0.000 claims description 16
- 102000036639 antigens Human genes 0.000 claims description 15
- 108091007433 antigens Proteins 0.000 claims description 15
- 239000000523 sample Substances 0.000 claims description 14
- 239000013060 biological fluid Substances 0.000 claims description 12
- 102000015636 Oligopeptides Human genes 0.000 claims description 9
- 108010038807 Oligopeptides Proteins 0.000 claims description 9
- 239000007790 solid phase Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 8
- 230000003993 interaction Effects 0.000 claims description 8
- 230000003278 mimic effect Effects 0.000 claims description 8
- 102000053602 DNA Human genes 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 210000000170 cell membrane Anatomy 0.000 claims description 6
- 102000006240 membrane receptors Human genes 0.000 claims description 6
- 108020004084 membrane receptors Proteins 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 108010077805 Bacterial Proteins Proteins 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 5
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 108090000565 Capsid Proteins Proteins 0.000 claims description 4
- 102100023321 Ceruloplasmin Human genes 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 102000018358 immunoglobulin Human genes 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 239000013566 allergen Substances 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 101710120037 Toxin CcdB Proteins 0.000 claims description 2
- 230000004071 biological effect Effects 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 229940072221 immunoglobulins Drugs 0.000 claims description 2
- 230000000977 initiatory effect Effects 0.000 claims description 2
- 230000009870 specific binding Effects 0.000 claims description 2
- 238000005070 sampling Methods 0.000 claims 1
- 230000003321 amplification Effects 0.000 abstract description 21
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 21
- 239000000126 substance Substances 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 101100338243 Caenorhabditis elegans hil-6 gene Proteins 0.000 description 7
- 239000011324 bead Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 239000011543 agarose gel Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 102000004889 Interleukin-6 Human genes 0.000 description 4
- 108090001005 Interleukin-6 Proteins 0.000 description 4
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 4
- 229960005542 ethidium bromide Drugs 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 239000006180 TBST buffer Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 description 1
- 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 1
- 102000010781 Interleukin-6 Receptors Human genes 0.000 description 1
- 108010038501 Interleukin-6 Receptors Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 101000582398 Staphylococcus aureus Replication initiation protein Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 108700011201 Streptococcus IgG Fc-binding Proteins 0.000 description 1
- 241001468181 Streptococcus sp. 'group C' Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 241000251221 Triakidae Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960001269 glycine hydrochloride Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 102000052611 human IL6 Human genes 0.000 description 1
- 102000052623 human IL6R Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 108700010839 phage proteins Proteins 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.生物学的サンプル中の関心分子の存在を検出する方法において、 a)ファージの表面に暴露された分子と相互作用する能力を破壊することなく 関心分子を固定化し、 b)上述のように固定化された関心分子を、内部にその配列が少なくとも部分 的に既知の一本鎖DNA分子を有し、生物学的サンプル中に存在する少なくとも 1個の関心分子に特異的に結合できる少なくとも1種の分子がカプシドの表面上 に暴露された少なくとも1個の組換え線状バクテリオファージと、特異的結合を 生じさせ、 c)この方法で得られた分子-バクテリオファージ複合体を、反応混合物から 分離し、 d)分子とバクテリオファージの間の非特異的相互作用によって発生した複合 体を除去するために洗浄し、 e)以下のg)に記載の操作を実施するための試薬を添加し、 f)このように選択されたバクテリオファージタンパク質カプシドを形成する タンパク質を溶解させ、 g)上述のようにして得られたDNAをポリメラーゼチェーン反応(PCR) によって増幅し、 h)上述のように増幅されたDNAを検出することからなる方法。 2.f)で示された操作はDNAの変性が起こる温度で実施して、g)で示さ れた以後の操作工程を形成し、これはカプシドタンパク質の溶解後直ちに同じ温 度で行い、すなわちPCRの「熱開始」を達成することからなる「請求項1」記 栽の方法。 3.関心分子は抗体である生物学的サンプル中の関心分子を検出する「請求項 1および2」のいずれに記載の方法。 4.関心分子は固相に固定化される生物学的サンプル中の関心分子を検出する 「請求項1〜3」のいずれに記載の方法。 5.関心分子の固相上への固定化は受動吸着によって行われる生物学的サンプ ル中の関心分子を検出する「請求項4」記載の方法。 6.関心分子の固相上への固定化はその分子自体に特異的な抗体の使用により 行われる生物学的サンプル中の関心分子を検出する「請求項4」記載の方法。 7.分子の固相上への固定化は、細菌またはStaffi1ococcus Aureusのプロテ インA、グループC StreptococciのプロテインG、および動物免疫グロブリン に結合できる任意の他の細菌性タンパク質からなる群より選択される細菌性タン パク質少なくとも1種の使用により行われる生物学的サンプル中の関心分子を検 出する「請求項3」記載の方法。 8.バクテリオファージはカプシドの表面上にウイルス抗原、その部分または 検討下にある生物学的液体中のそれらの存在の効果を模倣できるオリゴペプチド を示す、生物学的サンプル中の関心分子を検出する「請求項1〜7」のいずれか に記載の方法。 9.バクテリオファージはカプシドの表面上に自己抗原、その部分または検討 下にある生物学的液体中のそれらの存在の効果を模倣できるオリゴペプチドを示 す、生物学的サンプル中の関心分子を検出する「請求項1〜7」のいずれかに記 載の方法。 10.バクテリオファージはカプシドの表面上にアレルゲン、その部分または検 討下にある生物学的液体中のそれらの存在の効果を模倣できるオリゴペプチドを 示す、生物学的サンプル中の関心分子を検出する「請求項1〜7」のいずれかに 記載の方法。 11.バクテリオファージはカプシドの表面上に細胞膜受容体、それらの受容体 の部分またはそれらの生物活性を模倣できるオリゴペプチドを示す、生物学的サ ンプル中の関心分子を検出する「請求項1〜7」のいずれかに記載の方法。 12.バクテリオファージはカプシドの表面上に特異的細胞膜受容体、またはそ れらから誘導されるペプチドを示す、生物学的サンプル中の関心分子を検出する 「請求項1〜7」のいずれかに記載の方法。 13.バクテリオファージはカプシドの表面上に、試験される液体中にその受容 体が存在すると思われるアミノ酸の性質のリガンドを示す、生物学的サンプル中 の関心分子を検出する「請求項1〜7」のいずれかに記載の方法。 14.バクテリオファージはカプシドの表面上に「請求項11〜16」のいずれかに 記載の分子をともに示す、生物学的サンプル中の関心分子を検出する「請求項1 〜7」のいずれかに記載の方法。 15.上に記載、例示および請求された、生物学的サンプル中の関心分子を検出 する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000304A IT1291913B1 (it) | 1997-05-22 | 1997-05-22 | Metodo che prevede l'uso di batteriofagi per la rivelazione della presenza di molecole di interesse in campioni biologici |
IT97A000304 | 1997-05-22 | ||
PCT/IT1998/000130 WO1998053100A1 (en) | 1997-05-22 | 1998-05-22 | Method based on the use of bacteriophages for the detection biological molecules in biological samples |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000513949A true JP2000513949A (ja) | 2000-10-24 |
JP3143477B2 JP3143477B2 (ja) | 2001-03-07 |
Family
ID=11405087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10550211A Expired - Fee Related JP3143477B2 (ja) | 1997-05-22 | 1998-05-22 | 生物学的サンプル中における生物学的分子の検出のためのバクテリオファージの使用に基づく方法 |
Country Status (15)
Country | Link |
---|---|
US (1) | US6265169B1 (ja) |
EP (1) | EP0983386B1 (ja) |
JP (1) | JP3143477B2 (ja) |
CN (1) | CN1261407A (ja) |
AT (1) | ATE286540T1 (ja) |
AU (1) | AU733215B2 (ja) |
CA (1) | CA2290740C (ja) |
DE (1) | DE69828502T2 (ja) |
EA (1) | EA199901057A1 (ja) |
ES (1) | ES2235329T3 (ja) |
IL (1) | IL132980A0 (ja) |
IT (1) | IT1291913B1 (ja) |
NO (1) | NO995700L (ja) |
PT (1) | PT983386E (ja) |
WO (1) | WO1998053100A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006520592A (ja) * | 2003-03-04 | 2006-09-14 | イギリス国 | 試料中の分析物を測定するための結合成分を発現するウイルスの使用 |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000006717A2 (en) | 1998-07-27 | 2000-02-10 | Genentech, Inc. | Improved transformation efficiency in phage display through modification of a coat protein |
GB9912743D0 (en) * | 1999-06-02 | 1999-08-04 | Proteome Sciences Plc | Method and kit for ligand assay |
US20020192676A1 (en) * | 2001-06-18 | 2002-12-19 | Madonna Angelo J. | Method for determining if a type of bacteria is present in a mixture |
DE10129815A1 (de) * | 2001-06-24 | 2003-01-09 | Profos Ag | Verfahren zur Aufreinigung von Bakterienzellen und Zellbestandteilen |
US20050003346A1 (en) * | 2002-04-12 | 2005-01-06 | Colorado School Of Mines | Apparatus and method for detecting microscopic living organisms using bacteriophage |
US8216780B2 (en) * | 2002-04-12 | 2012-07-10 | Microphage (Tm) Incorporated | Method for enhanced sensitivity in bacteriophage-based diagnostic assays |
CA2482173C (en) * | 2002-04-12 | 2012-10-23 | Colorado School Of Mines | Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells |
DK1644513T3 (da) * | 2003-06-20 | 2011-10-17 | Discoverx Corp | Assay til detektion af proteinbinding |
US20050250096A1 (en) * | 2004-02-13 | 2005-11-10 | Microphage, Incorporated | Microorganism detection using bacteriophage amplification |
US20080241819A1 (en) * | 2006-10-31 | 2008-10-02 | Microphage (Tm) Incorporated | Method and apparatus for enhanced bacteriophage-based diagnostic assays by selective inhibition of potential cross-reactive organisms |
US20110097702A1 (en) * | 2005-03-31 | 2011-04-28 | Voorhees Kent J | Methods and compositions for in situ detection of microorganisms on a surface |
US8092990B2 (en) * | 2005-03-31 | 2012-01-10 | Colorado School Of Mines | Apparatus and method for detecting microscopic organisms using bacteriophage |
US20070178450A1 (en) * | 2006-01-27 | 2007-08-02 | Microphage (Tm) Incorporation | Method and apparatus for determining level of microorganisms using bacteriophage |
CN100386628C (zh) * | 2006-04-21 | 2008-05-07 | 中国科学院武汉病毒研究所 | 噬菌体免疫pcr检测病原的方法 |
CA2690809A1 (en) | 2007-06-15 | 2008-12-24 | Microphage Incorporated | Method of detection of microorganisms with enhanced bacteriophage amplification |
US8697434B2 (en) * | 2008-01-11 | 2014-04-15 | Colorado School Of Mines | Detection of phage amplification by SERS nanoparticles |
ES2325825B1 (es) * | 2008-03-17 | 2010-06-25 | Consejo Superior De Investigaciones Cientificas (Csic) (75%) | Procedimiento y sistema para detectar y/o cuantificar bacteriofagos susceptibles de infectar una cepa huesped bacteriana predeterminada, uso de un dispositivo microelectronico sensor para detectar dichos bacteriofagos y dispositivo microelectronico sensor para llevar a cabo dicho. |
US9441204B2 (en) * | 2008-04-03 | 2016-09-13 | Colorado School Of Mines | Compositions and methods for detecting Yersinia pestis bacteria |
WO2010123626A1 (en) | 2009-04-24 | 2010-10-28 | University Of Southern California | Cd133 polymorphisms and expression predict clinical outcome in patients with cancer |
WO2011084757A1 (en) | 2009-12-21 | 2011-07-14 | University Of Southern California | Germline polymorphisms in the sparc gene associated with clinical outcome in gastric cancer |
WO2011085334A1 (en) | 2010-01-11 | 2011-07-14 | University Of Southern California | Cd44 polymorphisms predict clinical outcome in patients with gastric cancer |
JP2014063220A (ja) * | 2012-09-19 | 2014-04-10 | Sharp Corp | 情報処理装置、情報処理装置の制御方法、制御プログラム、および記録媒体 |
CA2907234A1 (en) | 2013-03-15 | 2014-09-25 | Altria Client Services Llc | Bacteriophage and methods of making and using |
US9781929B2 (en) | 2015-01-29 | 2017-10-10 | Altria Client Services Llc | Bacteriophage and methods of using |
WO2016123425A1 (en) | 2015-01-29 | 2016-08-04 | Altria Client Services Llc | Endolysin from bacteriophage against geobacillus and methods of using |
CN113265489B (zh) * | 2021-06-01 | 2021-12-14 | 广州医科大学 | 一种基于ms2噬菌体研究蛋白相互作用的新方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3590116T1 (ja) * | 1984-03-19 | 1987-02-19 | ||
US4957858A (en) | 1986-04-16 | 1990-09-18 | The Salk Instute For Biological Studies | Replicative RNA reporter systems |
US5077192A (en) * | 1988-10-25 | 1991-12-31 | The General Hospital Corporation | Method of detecting antigenic, nucleic acid-containing macromolecular entities |
JPH05149949A (ja) * | 1991-11-26 | 1993-06-15 | Nisshin Flour Milling Co Ltd | 新規な微量物質測定法 |
JPH07505765A (ja) * | 1992-02-04 | 1995-06-29 | イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー | 核酸の複製によるアッセイのリポーターの増幅 |
WO1993017129A1 (en) * | 1992-02-28 | 1993-09-02 | Judkins Paul W | Method and diagnostic kit for determination of bacteria |
IT1270939B (it) * | 1993-05-11 | 1997-05-26 | Angeletti P Ist Richerche Bio | Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili. |
IT1261693B (it) * | 1993-06-01 | 1996-05-29 | Angeletti P Ist Richerche Bio | Metodologia per la produzione di fagi filamentosi che espongono sulla superficie del capside peptidi capaci di legare la biotina, e fagi filamentosi e peptidi cosi' ottenibili. |
US5576197A (en) * | 1995-04-07 | 1996-11-19 | Molecular Bio-Products | Polymerase chain reaction container and methods of using the same |
-
1997
- 1997-05-22 IT IT97RM000304A patent/IT1291913B1/it active IP Right Grant
-
1998
- 1998-05-22 IL IL13298098A patent/IL132980A0/xx unknown
- 1998-05-22 US US09/424,302 patent/US6265169B1/en not_active Expired - Lifetime
- 1998-05-22 CA CA002290740A patent/CA2290740C/en not_active Expired - Fee Related
- 1998-05-22 EA EA199901057A patent/EA199901057A1/ru unknown
- 1998-05-22 DE DE69828502T patent/DE69828502T2/de not_active Expired - Lifetime
- 1998-05-22 ES ES98923056T patent/ES2235329T3/es not_active Expired - Lifetime
- 1998-05-22 AU AU75480/98A patent/AU733215B2/en not_active Ceased
- 1998-05-22 EP EP98923056A patent/EP0983386B1/en not_active Expired - Lifetime
- 1998-05-22 WO PCT/IT1998/000130 patent/WO1998053100A1/en active IP Right Grant
- 1998-05-22 AT AT98923056T patent/ATE286540T1/de not_active IP Right Cessation
- 1998-05-22 JP JP10550211A patent/JP3143477B2/ja not_active Expired - Fee Related
- 1998-05-22 PT PT98923056T patent/PT983386E/pt unknown
- 1998-05-22 CN CN98806434A patent/CN1261407A/zh active Pending
-
1999
- 1999-11-19 NO NO995700A patent/NO995700L/no not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006520592A (ja) * | 2003-03-04 | 2006-09-14 | イギリス国 | 試料中の分析物を測定するための結合成分を発現するウイルスの使用 |
Also Published As
Publication number | Publication date |
---|---|
PT983386E (pt) | 2005-04-29 |
US6265169B1 (en) | 2001-07-24 |
EP0983386A1 (en) | 2000-03-08 |
DE69828502D1 (de) | 2005-02-10 |
AU7548098A (en) | 1998-12-11 |
CN1261407A (zh) | 2000-07-26 |
EA199901057A1 (ru) | 2000-04-24 |
ATE286540T1 (de) | 2005-01-15 |
AU733215B2 (en) | 2001-05-10 |
DE69828502T2 (de) | 2006-01-05 |
ITRM970304A0 (ja) | 1997-05-22 |
JP3143477B2 (ja) | 2001-03-07 |
CA2290740C (en) | 2004-12-14 |
ES2235329T3 (es) | 2005-07-01 |
IT1291913B1 (it) | 1999-01-21 |
EP0983386B1 (en) | 2005-01-05 |
WO1998053100A1 (en) | 1998-11-26 |
NO995700D0 (no) | 1999-11-19 |
ITRM970304A1 (it) | 1998-11-22 |
NO995700L (no) | 2000-01-24 |
CA2290740A1 (en) | 1998-11-26 |
IL132980A0 (en) | 2001-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000513949A (ja) | 生物学的サンプル中における生物学的分子の検出のためのバクテリオファージの使用に基づく方法 | |
KR101290034B1 (ko) | 표적 물질의 검출 방법 | |
CN1875116B (zh) | 可溶性分析物的检测和扩增 | |
JP5656339B2 (ja) | タンパク質固定化担体およびその製造方法 | |
US20050026161A1 (en) | Displacement sandwich immuno-PCR | |
CA2262403A1 (en) | Biomarkers and targets for diagnosis, prognosis and management of prostate disease | |
JP2000502887A (ja) | 生体分子の電子的固相アッセイ | |
Mustafakulov et al. | Prospects of aptamer application in diagnostics of bacterial infections | |
US20200149117A1 (en) | Kit and method for detecting target-tumor serum aptamer complex | |
CN110178031A (zh) | 寨卡病毒感染的血清学测定 | |
EP1169473B1 (en) | High sensitivity phage display biomolecule detection | |
AU773046B2 (en) | Test system for detecting different markers, and production and use thereof | |
US6268123B1 (en) | Direct and biochemically functional detection process of retrovirus in biological samples | |
CN114410640B (zh) | 一种用于检测麻疹病毒的核酸适配体、试剂盒及应用 | |
WO2008004706A1 (fr) | Procédé de détection d'une substance cible à l'aide d'un procédé d'amplification de l'acide nucléique, disponible dans des conditions thermostatiques | |
US20050239078A1 (en) | Sequence tag microarray and method for detection of multiple proteins through DNA methods | |
JP2004512500A (ja) | 分子形状の識別方法 | |
JPH04286957A (ja) | 遺伝子検出方法 | |
EP4305418A1 (en) | Multiply labelled polymeric constructs for detection assays | |
JP2002181821A (ja) | 複数検査多重化用懸濁液およびその懸濁液を用いた複数検査多重化方法 | |
US20090203548A1 (en) | Complex able to detect an analyte, method for its preparation and uses thereof | |
JPH03128000A (ja) | 核酸の検出法及び検出試薬 | |
JPH06141896A (ja) | 高感度測定法 | |
JPH03257371A (ja) | 免疫学的測定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071222 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081222 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091222 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101222 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111222 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111222 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121222 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121222 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131222 Year of fee payment: 13 |
|
LAPS | Cancellation because of no payment of annual fees |